Recombinant Neisseria meningitidis serogroup A / serotype 4A UPF0756 membrane protein NMA2160 (NMA2160)

Shipped with Ice Packs
In Stock

Description

Protein Overview

NMA2160 is a 148-amino-acid membrane protein encoded by the nma2160 gene in Neisseria meningitidis serogroup A, strain Z2491. It belongs to the UPF0756 family of uncharacterized membrane proteins and is annotated as an inner membrane protein with potential roles in bacterial physiology or virulence .

Key Features:

  • UniProt ID: A1ITY7

  • Gene Name: nma2160

  • Synonyms: UPF0756 membrane protein NMA2160

  • Sequence Length: Full-length (1-148 residues)

Epidemiological Context

Neisseria meningitidis serogroup A is historically linked to epidemics in sub-Saharan Africa’s meningitis belt. Strain Z2491, the source of NMA2160, has a 2.18 Mb genome encoding ~2,000 genes, including virulence factors like capsular polysaccharides . Recombinant NMA2160 provides a tool to study adaptive mechanisms in meningococcal pathogenesis, particularly amid reports of urogenital infections caused by atypical serogroups .

Quality Control and Stability

  • Purity: Validated via SDS-PAGE and Western blot .

  • Activity: Retains structural integrity post-reconstitution, as confirmed by immunoassays .

  • Storage Stability: Maintains functionality for months at -80°C with glycerol .

Future Directions

  • Mechanistic Studies: Elucidate NMA2160’s role in bacterial adhesion or immune evasion.

  • Multiplex Assays: Engineer subclass-switched monoclonal antibodies against NMA2160 for advanced co-labeling studies .

  • Vaccine Adjuvants: Evaluate its potential in next-generation meningococcal vaccines .

Product Specs

Form
Lyophilized powder
Please note: We will prioritize shipping the format we have in stock. However, if you require a specific format, kindly indicate your preference when placing your order. We will accommodate your request to the best of our ability.
Lead Time
Delivery time may vary based on the purchase method and location. Kindly consult your local distributors for specific delivery timeframes.
Note: All our proteins are shipped with standard blue ice packs by default. Should you require dry ice shipping, please communicate your preference in advance as an additional fee will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging this vial before opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We suggest adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard final concentration of glycerol is 50%, which can serve as a reference for your convenience.
Shelf Life
Shelf life is influenced by various factors including storage conditions, buffer ingredients, storage temperature, and the protein's inherent stability.
Generally, the shelf life of the liquid form is 6 months at -20°C/-80°C. For lyophilized form, the shelf life is 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during the production process. If you have a specific tag type requirement, please inform us and we will prioritize developing the specified tag.
Synonyms
NMA2160; UPF0756 membrane protein NMA2160
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-148
Protein Length
full length protein
Species
Neisseria meningitidis serogroup A / serotype 4A (strain Z2491)
Target Names
NMA2160
Target Protein Sequence
MNFSFAPLFLVTLILLGVVSNNNSITISATILLLMQQTALIQFVPLVEKHGLNLGIILLT IGVLSPLVSGKAQVPPVAEFLNFKMISAVFIGIFVAWLAGRGVPLMGQQPVLITGLLIGT VIGVAFMGGIPVGPLIAAGILSFVVGKG
Uniprot No.

Target Background

Database Links

KEGG: nma:NMA2160

Protein Families
UPF0756 family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is the structural composition of NMA2160 membrane protein?

NMA2160 is a membrane protein from Neisseria meningitidis serogroup A / serotype 4A (strain Z2491) with 148 amino acids in its full-length sequence. The protein has a hydrophobic profile consistent with membrane localization, featuring multiple transmembrane domains. The amino acid sequence is: MNFSFAPLFLVTLILLGVVSNNNSITISATILLLMQQTALIQFVPLVEKHGLNLGIILLTIGVLSPLVSGKAQVPPVAEFLNFKMISAVFIGIFVAWLAGRGVPLMGQQPVLITGLLIGTVIGVAFMGGIPVGPLIAAGILSFVVGKG . This sequence suggests a typical membrane protein structure with hydrophobic regions that likely span the bacterial membrane.

What expression systems are recommended for producing recombinant NMA2160?

  • Using specialized E. coli strains designed for membrane protein expression

  • Employing tag systems that enhance solubility (such as MBP or SUMO fusion tags)

  • Optimizing expression conditions (temperature, induction time, media composition)

  • Considering alternative expression systems such as yeast (P. pastoris) or insect cells for proteins requiring post-translational modifications

The choice of expression system should be guided by the specific research objectives and downstream applications, particularly considering that NMA2160 is normally expressed in the bacterial membrane environment .

What purification strategies are effective for NMA2160?

Purification of membrane proteins like NMA2160 typically requires specialized approaches:

Purification StepRecommended MethodConsiderations
Membrane ExtractionDetergent solubilizationScreen multiple detergents (DDM, LDAO, etc.)
Initial CaptureIMAC (if His-tagged)Optimize detergent in buffers
Secondary PurificationSize exclusion chromatographyAssess protein stability and aggregation
Quality ControlSDS-PAGE, Western blotVerify purity and integrity

The protein is typically stored in a Tris-based buffer with 50% glycerol at -20°C for standard storage or -80°C for extended preservation. Repeated freeze-thaw cycles should be avoided, and working aliquots can be stored at 4°C for up to one week .

How does the membrane topology of NMA2160 influence its function in Neisseria meningitidis?

Understanding the membrane topology of NMA2160 requires integrating computational prediction with experimental validation. Based on its sequence characteristics (high proportion of hydrophobic residues and membrane-spanning segments), NMA2160 likely adopts a multi-pass transmembrane conformation. Experimental approaches to determine topology include:

  • Protease accessibility assays with membrane-impermeable proteases

  • Site-directed fluorescence labeling at predicted loop regions

  • Cysteine scanning mutagenesis combined with accessibility assays

  • Cryo-EM structural studies for definitive topology mapping

The functional implications of this topology may relate to bacterial membrane integrity, transport functions, or signaling pathways, though specific functions remain to be experimentally established.

What are the challenges in resolving contradictory data when studying NMA2160 function?

When faced with contradictory experimental results regarding NMA2160 function, researchers should implement systematic approaches to resolve discrepancies:

What experimental designs are most appropriate for studying NMA2160 protein-protein interactions?

When investigating protein-protein interactions involving NMA2160, researchers should consider the following experimental design framework:

  • Define variables clearly:

    • Independent variables: Potential binding partners, environmental conditions (pH, ion concentration)

    • Dependent variables: Binding affinity, complex formation, functional consequences

    • Control variables: Protein concentration, buffer composition, temperature

  • Formulate testable hypotheses:

    • Null hypothesis (H0): "NMA2160 does not interact with protein X under physiological conditions"

    • Alternative hypothesis (H1): "NMA2160 forms stable complexes with protein X under physiological conditions"

  • Design treatments systematically:

    • Vary binding partners and conditions systematically

    • Include appropriate controls (non-binding protein partners, denatured proteins)

    • Consider dose-response relationships to establish specificity

  • Methods selection matrix:

Interaction AspectPrimary MethodValidation MethodControls Required
Physical bindingPull-down assaysSurface plasmon resonanceGST-only or similar tag controls
In vivo associationCo-immunoprecipitationProximity ligation assayNon-specific antibody controls
Binding specificityCompetitive binding assaysMutagenesis of binding interfacesConcentration gradients of competitors
Structural basisHydrogen-deuterium exchangeCross-linking mass spectrometryBinding-deficient mutants

How should researchers design experiments to determine the function of NMA2160 in bacterial pathogenesis?

A comprehensive experimental design to investigate NMA2160's role in pathogenesis should include:

  • Gene knockout and complementation studies:

    • Generate NMA2160 deletion mutants using appropriate genetic tools

    • Create complementation strains with wild-type and mutant variants

    • Evaluate phenotypes under various growth and stress conditions

  • True experimental design elements:

    • Use control groups (wild-type, complemented strains) alongside experimental groups (knockout)

    • Implement random assignment of bacterial cultures to different treatment conditions

    • Blind assessment of phenotypic outcomes where possible

  • Infection model experiments:

    • Cellular models: Adhesion/invasion assays with relevant host cells

    • Animal models: Colonization, dissemination, and virulence assessment

    • Immunological responses: Cytokine production, immune cell recruitment

  • Methodological controls:

    • Off-target effect assessment through whole-genome sequencing of mutants

    • Phenotype verification using multiple independent mutant clones

    • Polar effect evaluation through transcript analysis of flanking genes

How should missing data be handled in experiments involving NMA2160?

When analyzing experimental data involving NMA2160, researchers often encounter missing data points due to technical failures, contamination, or other issues. Based on methodological research, the following approaches are recommended:

  • Assessment of missing data mechanism:

    • Missing Completely At Random (MCAR): Missing values unrelated to observed or unobserved data

    • Missing At Random (MAR): Missing values related to observed data

    • Missing Not At Random (MNAR): Missing values related to unobserved data

  • Strategy selection based on proportion of missing data:

    • Low missing data (<5%): Exclusion or simple imputation generally perform adequately

    • Moderate missing data (5-20%): More sophisticated imputation methods recommended

    • High missing data (>20%): Modeling approaches accounting for uncertainty perform better

  • Impact on statistical parameters:

    • Strategies ignoring uncertainty about missing data lead to more precise but potentially biased estimates

    • Methods accounting for uncertainty produce more conservative but reliable estimates

    • Between-trial variance can be artificially increased when missing data handling is inappropriate

What statistical approaches are appropriate for analyzing NMA2160 structure-function relationship data?

Structure-function analyses require sophisticated statistical approaches:

  • Correlation analysis between structural features and functional outcomes:

    • Pearson/Spearman correlations for continuous variables

    • Point-biserial correlations for dichotomous vs. continuous variables

    • Appropriate for initial hypothesis generation

  • Regression modeling to quantify relationships:

    • Multiple regression for controlling confounding variables

    • Hierarchical regression to test specific structural determinants

    • Inclusion of interaction terms for complex structure-function relationships

  • Multivariate approaches for complex datasets:

    • Principal Component Analysis to identify key structural variables

    • Structural Equation Modeling to test causal relationships

    • Cluster Analysis to identify functional groups based on structural features

What emerging technologies show promise for advancing NMA2160 research?

Several cutting-edge technologies offer new opportunities for understanding NMA2160:

  • AlphaFold2 and other AI structure prediction tools:

    • Application to NMA2160 to predict detailed structural features

    • Integration with experimental data for refined structural models

    • Structure-based function prediction through comparison with known proteins

  • Single-molecule techniques:

    • FRET studies to assess conformational changes in real-time

    • Force spectroscopy to measure interaction strengths

    • Single-molecule tracking in live bacteria to assess dynamics

  • Nanobody and aptamer development:

    • Generation of specific binding molecules for NMA2160

    • Applications in localization, purification, and functional studies

    • Potential therapeutic development targeting NMA2160

How can systems biology approaches enhance our understanding of NMA2160's role in bacterial physiology?

Systems biology offers comprehensive frameworks for understanding NMA2160:

  • Multi-omics integration:

    • Transcriptomics: Expression patterns under various conditions

    • Proteomics: Interaction partners and post-translational modifications

    • Metabolomics: Impact of NMA2160 disruption on bacterial metabolism

  • Network analysis:

    • Protein-protein interaction networks incorporating NMA2160

    • Regulatory networks affecting and affected by NMA2160

    • Metabolic flux analysis in wild-type vs. mutant strains

  • Mathematical modeling:

    • Kinetic models of processes involving NMA2160

    • Population-level models of bacterial growth and survival

    • Host-pathogen interaction models incorporating NMA2160 function

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.